Adjusted EBITDA -- $0.3 million positive, marking the second consecutive quarter in positive territory. Gross Margin -- 54.8% ...

Ladies and gentlemen, thank you for standing by for the Cigna Group's First Quarter 2026 Results Review. [Operator Instructions] As a reminder, ladies and gentlemen, this conference, including the Q&A ...

Read insights into the challenges facing NHS data, and the solutions available to resolve them - essential reading for anyone ...

Allegro MicroSystems' margin compression and operational inflexibility during downturns highlight structural risks. See why I rate ALGM stock a Sell.

2026 Financial Guidance Raised -- Revenue range increased to $2.275 billion to $2.375 billion, adjusted EBITDA range to $460 million-$480 million, and free cash flow increased to $215 million-$235 ...

GAAP net income -- $645,000, or $0.01 per diluted share, compared to a net loss of $8.1 million in 2025 and $4.9 million last quarter. Non-GAAP net income -- $11.8 million, or $0.20 per diluted share, ...

Earnings call Vivos Therapeutics delivered 16% YoY revenue growth to $17 million in 2025, driven by the SCN acquisition and new sleep center-focused model, despite legacy revenue declines and higher ...

United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 Earnings Call Transcript May 6, 2026 United Therapeutics Corporation ...

Allied Market Research published a report titled," Weight Management Market Size was valued at USD 144.6 billion in 2023 and ...

Following the successful issuance of the Asian Development Bank’s (ADB) first catastrophe bond offerings, Roberta Casali, ...

CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end ...

Microsoft reported Q3 results, with CEO Satya Nadella outlining a shift to per-seat plus consumption-based AI and agent ...